多模式成像下视网膜网状假性玻璃膜疣的发病率与危险因素
基于法国77岁及以上人群的ALIENOR队列,采用彩色眼底照相、频域OCT、眼底自发荧光和近红外反射四种成像中至少两种诊断视网膜网状假性玻璃膜疣(RPD),分析472只眼的发病率和危险因素。结果显示RPD年发病率为2.9%,5年风险13.5%;亚中央凹脉络膜变薄及ARMS2、CFH、LIPC基因变异增加风险,亲脂性他汀治疗与较低发病率相关。
要点
- 多模式成像下RPD年发病率为2.9%,5年风险13.5%,高于既往仅用彩照的估计。
- 亚中央凹脉络膜变薄及ARMS2、CFH、LIPC基因变异是RPD发病的危险因素。
- 亲脂性他汀治疗与RPD发病率降低相关(HR 0.13)。
核心结论
- 使用多模式成像时RPD发病率高于既往基于彩色眼底图像的人群研究。
- 亚中央凹脉络膜变薄或携带ARMS2、CFH、LIPC minor等位基因变异者RPD风险增加,而亲脂性他汀治疗与较低发病率相关。
研究设计与样本
- ALIENOR研究为法国77岁及以上人群队列,数据收集于2011年2月22日至2017年2月15日,平均随访3.7(1.0)年(范围1.2-5.6年)。
- 基线501人符合条件,1002只眼中排除197只(患病RPD、晚期年龄相关性黄斑变性或图像不可分级),剩余805只眼中333只缺失随访数据,最终统计分析纳入472只眼。
主要发现
- 472只眼中263只(55.7%)来自女性,平均(SD)年龄81.9(3.2)岁。
- 亲脂性他汀治疗与RPD发病率降低相关(HR 0.13;95%CI 0.02-0.74;P=0.02)。
关键数值与推荐
- RPD判定标准:彩色眼底照相、眼底自发荧光、近红外反射和频域OCT四种成像方法中至少两种检测到RPD。
临床怎么用
- 对77岁及以上人群,采用多模式成像可提高RPD检出,不应仅依赖彩色眼底照相。
- 亚中央凹脉络膜变薄或携带ARMS2、CFH、LIPC风险变异者应警惕RPD发生。
- 亲脂性他汀治疗可能与较低RPD发病率相关,但需进一步研究验证。
局限性
- 805只眼中333只缺失随访数据,最终仅472只眼纳入分析。
- 研究人群为法国77岁及以上个体,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although retinal multimodal imaging is needed for diagnosing reticular pseudodrusen (RPD), the incidence of RPD in the general population typically has been assessed only using fundus photographs, which may underestimate their incidence. OBJECTIVES: To describe the incidence of RPD using retinal color photographs, spectral-domain optical coherence tomography scans, fundus autofluorescence, and near-infrared reflectance images among individuals 77 years of age or older and to analyze the associated risk factors of RPD. DESIGN, SETTING, AND PARTICIPANTS: The ALIENOR (Antioxydants, Lipides Essentiels, Nutrition et Maladies Oculaires) Study is a cohort of French individuals 77 years of age or older. Data for this study were collected between February 22, 2011, and February 15, 2017, with a mean (SD) follow-up of 3.7 (1.0) years (range, 1.2-5.6 years). At baseline, 501 individuals were eligible to participate. Of 1002 eyes, 197 had prevalent RPD, advanced age-related macular degeneration, or ungradable images. Of the remaining 805 eyes, 333 were missing follow-up data; therefore, the statistical analyses included data from 472 eyes. Data management and statistical analyses were performed between March 15, 2017, and April 5, 2019. MAIN OUTCOMES AND MEASURES: Reticular pseudodrusen were considered as present if detected by at least 2 of the following imaging methods: color fundus photographs, fundus autofluorescence, near-infrared reflectance, and spectral-domain optical coherence tomography images. RESULTS: Of the 472 eyes analyzed, 263 (55.7%) were from female participants, and the mean (SD) age was 81.9 (3.2) years. Forty-three eyes developed RPD, corresponding to an annual incidence rate of 2.9% (95% CI, 1.9%-4.4%) per participant and an estimated 5-year risk of 13.5%. In multivariable analysis, 4 risk factors of incident RPD were identified: subfoveal choroidal thinning (hazard ratio [HR], 0.99; 95% CI, 0.99-1.00 per 10-μm decrease in thickness; P = .02) and the presence of the minor allelic variants rs10490924 for ARMS2 (HR, 3.57; 95% CI, 1.80-7.10; P < .001), rs1061170 for CFH (HR, 2.12; 95% CI, 1.02-4.41; P = .04), and rs10468017 for LIPC (HR, 2.57; 95% CI, 1.37-4.82; P = .003). Lipophilic statin therapy was associated with a lower incidence of RPD (HR, 0.13; 95% CI, 0.02-0.74; P = .02). CONCLUSIONS AND RELEVANCE: With the use of multimodal imaging, the RPD incidence rate was higher than previously reported in other population-based studies using fundus color images. Individuals with subfoveal choroidal thinning or carrying minor allelic variants for ARMS2, CFH, or LIPC had an increased risk for RPD, whereas lipophilic statin therapy was associated with a lower incidence.
引用
- Dutheil C, Le Goff M, Cougnard-Grégoire A, et al. Incidence and Risk Factors of Reticular Pseudodrusen Using Multimodal Imaging. JAMA Ophthalmol. 2020. PMID: 32163116. doi:10.1001/jamaophthalmol.2020.0266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。